Recital 5, Commission Regulation (EC) No 1095/2007 of 20 September 2007 amending Regulation (EC) No…

In forcecited 2×

The resources of the EFSA should be used efficiently. Where there are clear indications that the active substance concerned meets the criteria referred to in Article 5(1) of Directive 91/414/EEC, and in particular does not have any harmful effects on humans or animal health or on groundwater or any unacceptable influence on the environment, that substance should be included in Annex I to that Directive. Such clear cases would not require detailed scientific advice from the EFSA before the substance is included in Annex I. The EFSA should, however, deliver its view on those substances later, in particular to ensure a harmonised approach when Member States apply the uniform principles at the evaluation of authorisations. Where, on the contrary, there are clear indications that an active substance has harmful affects; the Commission is not required to have this clear situation confirmed, so it should have the possibility to decide on non-inclusion without consulting the EFSA.

  • Judgment of the General Court (Fifth Chamber) of 19 January 2012. Xeda International SA and Pace International LLC v European Commission.Decision

    19 Jan 2012 · 62010TJ0071

  • Judgment of the Court (Eighth Chamber) of 27 June 2013. Xeda International SA and Pace International LLC v European Commission.Decision

    According to recitals 5 and 6 in the preamble to Regulation No 1095/2007, the resources of the EFSA should be used efficiently and the EFSA should focus on cases where the remaining doubts need to be resolved before a decision on the …

    27 Jun 2013 · 62012CJ0149